PALOMA-3: Study Design and Baseline Characteristics

Opinion
Video

Panelists discuss how PALOMA-3, a phase 3 randomized clinical trial, was designed to evaluate palbociclib plus fulvestrant vs placebo plus fulvestrant in patients with hormone receptor–positive, HER2-negative advanced breast cancer who had progressed on prior endocrine therapy.

CN24_BTL_mNSCLC_Seg04_PALOMA-3-Study-Design
Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Related Content